BREATH THERAPEUTICS
LIVE

Serial Number

79256336

Owner

Breath Therapeutics GmbH

Attorney

Pina Campagna

Filing Date

Jan 31, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BREATH THERAPEUTICS Trademark

Serial Number: 79256336 • Registration: 6021036

BREATH THERAPEUTICS is a trademark filed by Breath Therapeutics GmbH on January 31, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Breath Therapeutics GmbH

Aldringenstrasse 4

Entity Type: 27

Trademark Details

Filing Date

January 31, 2019

Registration Date

March 31, 2020

Published for Opposition

January 14, 2020

Goods & Services

Pharmaceutical preparations for the treatment of lung diseases; respiratory pharmaceutical preparations namely, preparations for the treatment of conditions, disorders and diseases of the respiratory system; anti-inflammatory pharmaceutical preparations; immunosuppressive pharmaceutical preparations, namely, preparations for the treatment of disorders of the immune system and their effects on the respiratory system and preparations for use in connection with transplantations; anti-proliferative pharmaceutical preparations, namely, preparations inhibiting cell growth; cytostatic pharmaceutical preparations, namely, preparations for destroying tumor cells, medical diagnostic reagents

Medical diagnostic instruments for examining the respiratory system; respiratory monitors for medical use; respiratory sensors for medical use; medical apparatus for measuring lung function; respiratory therapy instruments, namely, aerosol dispensing devices being inhalers for medical use, spirometers and nebulizers; apparatus for the treatment of breathing difficulties, namely, inhalators for medical purposes; medical apparatus for assisting breathing; medical apparatus for training breathing techniques

Pharmaceutical research services; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; design and development of medical technology; design and development of medical diagnostic apparatus; design and development of computer software for use with medical technology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 31, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 9, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 9, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 30, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 10, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 25, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 25, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2019 NONP
ASSIGNED TO LIE
Dec 9, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 6, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 6, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 6, 2019 CNEA
ASSIGNED TO EXAMINER
Nov 19, 2019 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2019 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 11, 2019 ADCH
REFUSAL PROCESSED BY IB
Jun 1, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 15, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 15, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Apr 16, 2019 MAFR
ASSIGNED TO EXAMINER
Apr 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 11, 2019 REPR